# Hydroxychloroquine and Cognitive Function After Surgery

> **NCT03025087** · PHASE4 · TERMINATED · sponsor: **Duke University** · enrollment: 24 (actual)

## Conditions studied

- Individuals Undergoing Cardiac and General Surgery

## Interventions

- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT03025087
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-19
- **Primary completion:** 2023-05-22
- **Final completion:** 2024-04-19
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Showed no benefit
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03025087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03025087, "Hydroxychloroquine and Cognitive Function After Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03025087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*